Community

Community

Subject

While this schisto community is not terribly active right now there was just published an excellent open access issue of Future Med Chem, edited by Conor Caffrey, and with articles by many of the major players in the field.

Community

Subject

More fantastic work from Iain Wallace of ChEMBL, below. These are maps of active antimalarials and predicted targets, expressed as similarity maps, i.e. with an extra level of analysis added on top. This provides a very intuitive way of walking through related compounds to compare structures. How best do we use this kind of analysis - as a target guide, or as a "prediction of what to make next" guide?

Community

Subject

Welcome address at the Open Source Drug Discovery for Malaria meeting at The University of Sydney, February 24th 2012. Speaker is Professor Mary O'Kane, Chief Scientist and Engineer, New South Wales, Australia.

Community

Subject

In August 2011 my lab started an open source drug discovery for malaria project. We’ve been a) very excited about this idea, and b) very busy getting things started. It’s an unusual project, exciting not only because we might be able to change the world, but because it’s not clear how we might do it. To me, that’s the definition of good research – you not only don’t know whether it’s going to work, but you don’t even know how to go about doing it.

Community

Subject

Was alerted to this NCTT project/proposal for deuterated analogs of enantiopure PZQ, with the deuteration being used to slow metabolism. Would be interesting to see how many D's are incorporated, and where (presumably at least the 4' position). I hope they're using our resolution approach to make their enantiopure material. And I wonder what the deuteration does to the cost, on scale?
(original page http://nctt.nih.gov/27545311)